Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
Jong‐Min Oh, T. M. Rangarajan, Reeta Chaudhary, et al.
Molecules (2020) Vol. 25, Iss. 10, pp. 2356-2356
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Anticancer Activity of Natural and Synthetic Chalcones
Teodora Constantinescu, Claudiu N. Lungu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11306-11306
Open Access | Times Cited: 114
Chalcone: A Promising Bioactive Scaffold in Medicinal Chemistry
Gayathri Rajendran, Deepu Bhanu, Baladhandapani Aruchamy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1250-1250
Open Access | Times Cited: 68
Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors
Sandeep Bindra, Ehab M. Mostafa, Mohamed A. Abdelgawad, et al.
RSC Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi, Bijo Mathew, Daniela Secci, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112650-112650
Closed Access | Times Cited: 69
Biological Evaluation, DFT Calculations and Molecular Docking Studies on the Antidepressant and Cytotoxicity Activities of Cycas pectinata Buch.-Ham. Compounds
Jinnat Rahman, Abu Montakim Tareq, Md. Mohotasin Hossain, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 9, pp. 232-232
Open Access | Times Cited: 66
Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
Da-Jiang Zou, Renzheng Liu, Yangjing Lv, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Probing the inhibition of MAO-B by chalcones: an integrated approach combining molecular docking, ADME analysis, MD simulation, and MM-PBSA calculations
Jisna Jose, Jibin K. Varughese, Mohammad K. Parvez, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 4
Closed Access | Times Cited: 5
Oxime functionalized Chalcones: Unveiling a new class of Chalcones with potent Antiplasmodial activity against blood-stages of plasmodium falciparum in culture
Reeta Chaudhary, Ayushee, Vinoth Rajendran, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130143-130143
Closed Access
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
Bijo Mathew, Jong‐Min Oh, Roua S. Baty, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 29, pp. 38855-38866
Open Access | Times Cited: 38
Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations
Rani Sasidharan, Bo Hyun Eom, Jeong Hyun Heo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 188-197
Open Access | Times Cited: 33
An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects
Pratibha Sharma, Manjinder Singh
Life Sciences (2023) Vol. 320, pp. 121568-121568
Closed Access | Times Cited: 14
A Review of Biologically Active Oxime Ethers
Tomasz Kosmalski, Daria Kupczyk, Szymon Baumgart, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5041-5041
Open Access | Times Cited: 14
Dual-Target Inhibitors Based on Acetylcholinesterase: Novel Agents for Alzheimer's Disease
Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116810-116810
Closed Access | Times Cited: 4
Inhibition of Butyrylcholinesterase and Human Monoamine Oxidase-B by the Coumarin Glycyrol and Liquiritigenin Isolated from Glycyrrhiza uralensis
Geum Seok Jeong, Myung-Gyun Kang, Joon Yeop Lee, et al.
Molecules (2020) Vol. 25, Iss. 17, pp. 3896-3896
Open Access | Times Cited: 33
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Vishal Payyalot Vishal, Jong‐Min Oh, Ahmed Khames, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 850-850
Open Access | Times Cited: 29
Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease
Ewelina Królicka, Katarzyna Kieć‐Kononowicz, Dorota Łażewska
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 847-847
Open Access | Times Cited: 20
A structural approach to investigate halogen substituted MAO-B inhibitors using QSAR modeling, molecular dynamics, and conceptual DFT analysis
Naseer Maliyakkal, Iqrar Ahmad, Sunil Kumar, et al.
Journal of Saudi Chemical Society (2023) Vol. 27, Iss. 4, pp. 101675-101675
Open Access | Times Cited: 11
Design, Synthesis, and Fungicidal Activity against Rice Sheath Blight of Novel N-Acyl-1,2,3,4-tetrahydroquinoline Derivatives
Hongfei Wu, Xingxing Lu, Jingbo Xu, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 29, pp. 11026-11034
Closed Access | Times Cited: 9
Effects of Natural Monoamine Oxidase Inhibitors on Anxiety-Like Behavior in Zebrafish
Oihane Jaka, Iñaki Iturria, Marco van der Toorn, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
Structural Modifications on Chalcone Framework for Developing New Class of Cholinesterase Inhibitors
Ginson George, Vishal Payyalot Koyiparambath, Sukumaran Sunitha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3121-3121
Open Access | Times Cited: 15
Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson’s disease: Synthesis, biochemistry, and molecular dynamics study
Della Grace Thomas Parambi, Jong‐Min Oh, Sunil Kumar, et al.
Computational Biology and Chemistry (2023) Vol. 105, pp. 107899-107899
Closed Access | Times Cited: 7
Selected 1,3‐Benzodioxine‐Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors
Geum Seok Jeong, Swafvan Kaipakasseri, Sang Ryong Lee, et al.
ChemMedChem (2020) Vol. 15, Iss. 23, pp. 2257-2263
Closed Access | Times Cited: 18
Inhibition of monoamine oxidases by benzimidazole chalcone derivatives
Athulya Krishna, Jiseong Lee, Sunil Kumar, et al.
Applied Biological Chemistry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 6
Aldoxime- and hydroxy-functionalized chalcones as highly potent and selective monoamine oxidase-B inhibitors
Jong‐Min Oh, T. M. Rangarajan, Reeta Chaudhary, et al.
Journal of Molecular Structure (2021) Vol. 1250, pp. 131817-131817
Closed Access | Times Cited: 14
Development of a New Class of Monoamine Oxidase-B Inhibitors by Fine-Tuning the Halogens on the Acylhydrazones
Jayalakshmi Jayan, Jiseong Lee, Sunil Kumar, et al.
ACS Omega (2023) Vol. 8, Iss. 50, pp. 47606-47615
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top